Clive Roberts,
Professor of Pharmaceutical Nanotechnology and Head of School of Pharmacy,
University of Nottingham
Clive Roberts is Professor of Pharmaceutical Nanotechnology at the School of Pharmacy, University of Nottingham. He graduated in physics from Imperial College in 1987, receiving a PhD in surface physics, also from Imperial College in 1991. He is currently Head of the School of Pharmacy and in the past has been a Director of the Nottingham Nanotechnology Centre (2007-2013). His research is focussed on improving methods to develop new medicines, which has led to over 270 research publications. He has been actively involved in the organization of major public understanding of science events focussed on Nanotechnology, engaging directly with tens of thousands of members of the public (nanoinNottingham, NanoWhat?, Flights of Fancy). Recently he has been involved in public exhibitions related to 3D printing of Medicines (Science Museum London, 2013-14, Manchester Science Museum 2014-2015). He was a co-founder of Molecular Profiles Limited, a successful spin-out exploiting nanotechnology based characterization in the pharmaceutical sector, which has won a number of awards including two Queen’s Award for Industry 2007/2011 and was recently acquired by Columbia Laboratories Inc. Finally, he is also one of the founders of Eminate Ltd, which develops solutions for improved health in foods, and has recently secured two global licence deals with Tate & Lyle for its salt reduction product, SodoLoTM, a product now launched around the world.
3D Printing Manufacture of Medicines
Wednesday, 18 October 2017 at 14:00
Add to Calendar ▼2017-10-18 14:00:002017-10-18 15:00:00Europe/London3D Printing Manufacture of MedicinesBioprinting and 3D Printing in the Life Sciences Europe in Cripps Court, Magdalene College, Cambridge, UK Cripps Court, Magdalene College, Cambridge, UK SELECTBIOenquiries@selectbiosciences.com
The processes used to produce tablets, the dominant form of medicine taken by patients, have changed relatively little for over a century. Whilst these approaches serve the industry and patients very well they remain limited in some clinical areas and cannot create complex dosage forms or bespoke medications tailored for an individual or sub-population (ie personalised medicines). This would be valuable in meeting therapeutic challenges and the need for personalized medicines. 3D printing, offers a possible route to address these issues. I will show tablets produced using extrusion and ink-jet methods and amongst other examples, a 5-drug polypill and tablets with novel 3D architecture designed to control drug release. The potential and challenges for using 3DP in the manufacture of medicines and to provide new opportunities for clinical practice will be discussed as well as the considerable challenges that must be met to satisfy scale-up issues and regulatory requirements. I aim to show that 3D printing has already shown the capacity to meet some regulatory requirements and whilst many challenges remain this is a technology that could potentially benefit patients and radically alter the way we make and distribute some medicines.
Add to Calendar ▼2017-10-17 00:00:002017-10-18 00:00:00Europe/LondonBioprinting and 3D Printing in the Life Sciences EuropeBioprinting and 3D Printing in the Life Sciences Europe in Cripps Court, Magdalene College, Cambridge, UK Cripps Court, Magdalene College, Cambridge, UK SELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2017-10-18 14:00:002017-10-18 15:00:00Europe/London3D Printing Manufacture of MedicinesBioprinting and 3D Printing in the Life Sciences Europe in Cripps Court, Magdalene College, Cambridge, UK Cripps Court, Magdalene College, Cambridge, UK SELECTBIOenquiries@selectbiosciences.com
